Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Chubb
Cantor Fitzgerald
Farmers Insurance
Federal Trade Commission
McKinsey
AstraZeneca
Baxter
Moodys

Generated: February 25, 2018

DrugPatentWatch Database Preview

Cytarabine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cytarabine and what is the scope of cytarabine patent protection?

Cytarabine
is the generic ingredient in four branded drugs marketed by Pacira Pharms Inc, Fresenius Kabi Usa, Hong Kong, Hospira, Mylan Labs Ltd, Teva Parenteral, West-ward Pharms Int, Teva Pharms Usa, and Celator Pharms, and is included in seventeen NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for cytarabine. Six suppliers are listed for this compound.
Pharmacology for cytarabine
Medical Subject Heading (MeSH) Categories for cytarabine

US Patents and Regulatory Information for cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd CYTARABINE cytarabine INJECTABLE;INJECTION 201784-001 Jan 30, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd CYTARABINE cytarabine INJECTABLE;INJECTION 200914-001 Dec 13, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Celator Pharms VYXEOS cytarabine; daunorubicin POWDER;IV (INFUSION) 209401-001 Aug 3, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
West-ward Pharms Int CYTARABINE cytarabine INJECTABLE;INJECTION 071471-001 Aug 2, 1989 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa CYTOSAR-U cytarabine INJECTABLE;INJECTION 075206-002 Dec 30, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Celator Pharms VYXEOS cytarabine; daunorubicin POWDER;IV (INFUSION) 209401-001 Aug 3, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CYTARABINE cytarabine INJECTABLE;INJECTION 074245-001 Aug 31, 1994 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-003 Dec 21, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-004 Dec 21, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira CYTARABINE cytarabine INJECTABLE;INJECTION 072945-001 Feb 28, 1994 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Medtronic
Dow
Chinese Patent Office
Cerilliant
McKinsey
Fish and Richardson
Mallinckrodt
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot